Clinical Trials Logo

Newly Diagnosed Glioblastoma clinical trials

View clinical trials related to Newly Diagnosed Glioblastoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04065087 Withdrawn - Clinical trials for Newly Diagnosed Glioblastoma

Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma

Start date: August 22, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2, randomized, placebo-controlled study to evaluate safety, tolerability, anti-tumor activity and impact on absolute lymphocyte count of GX-I7 plus adjuvant temozolomide combination regimen in patients with newly diagnosed with glioblastoma who completed standard concurrent chemo-radiation therapy (CCRT)